Example combined protocol: Morning: CJC-1295 (100mcg) + Ipamorelin (100mcg) Evening: GHK-CU (1-2mg) Separating administration times prevents potential interactions at the injection site and allows each peptide to work through its distinct pathways without interference
Specifically, BPC-157 has been shown to reduce the levels of Interleukin-1 beta (IL-1), Interleukin-6 (IL-6), and Tumor Necrosis Factor-alpha (TNF-)
This approach from SeekPeptides protocols minimizes irritation while maximizing benefits
This triple-peptide blend is a comprehensive recovery solution targeting both the root causes of inflammation and the repair mechanisms of damaged tissue
Its a risk that shows up as sourcing problems, insurer scrutiny, state board attention, and potential FDA action
Alpha Hydroxy Acids (AHAs) and Beta Hydroxy Acids (BHAs): These exfoliating acids can also lower skin pH and potentially cause irritation when combined with GHK-Cu